the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
September 21, 2022 – Here, a big bias in genetic research into its applicability on “personalized”, or “precision”, or “theragenomic” medicine is finally addressed and brought forward to all involved in these fields. The problem until now is (and was} that …
October 28, 2017 – How Precise is Precision Medicine When Applied to Diverse Populations? This was the question raised in a very recent article published in Front Line Genomics that is based an an according study published online October 19, 2017, …
Is precision medicine un-precise when applied to diverse world populations? Read more »
June 16, 2017 – Patient education in pharmacogenetics, the central component of theragenomic and personalized medicine and individualized drug safety is an important issue. Not only needs the individual patient to understand what pharmacogenetics, or more precisely, pharmacogenetic testing can …
Development of a patient education video about pharmacogenetics Read more »
July 9, 2016 – This is a huge step into the future of theragenomic and personalized medicine and individualized drug safety. In support of the President’s Precision Medicine Initiative (PMI), the American Food & Drug Administration (FDA) just issued two …
Precision Medicine Initiative: draft guidances issued Read more »